Nanalysis Scientific Corp (NSCI)

[gever]

I like the company and the management a lot, great prospectives. But what the heck. I recently supported the pps when it was on a serious downturn just to find out a couple of days later that they are issuing an offering at 1.1cad. Not the best timing!!!

[crmar]

I don't think timing is important here . They know what they are doing .
Some time ago they bought 5% of their own stock because they said that
the company was undervalued . So now they are acquiring another company
that suits in their trajectory of growth .
They are quite unique with their nuclear products of that size .
As Walter said , they could become a unicorn ...
They are building their business and will probably be profitable in the
near future . I like the company and the management and i am happy
to be in it now , this is only the beginning .

grtz

[gever]

Any thoughts on the timing of this public offering seen the current pps and market sentiment?

[crmar]

Public offering 8 million .
Price 1,1 .

grtz

[crmar]

Totally agree Walter , the company isn't valued as it should be
in my opinion ,

grts

[walterc]

another step with the goal of becoming a unicorn.

[ctkrod]

Good to see them continue to execute their plan. How many acquisitions did Sean say they were targeting for 2022? 2-3?

[W_vdm]

https://ceo.ca/@newswire/nanalysis-enters-into-a-letter-of-intent-to-acquire

[futrcash]

https://www.prnewswire.com/news-releases/nanalysis-establishes-scientific-advisory-board-with-four-world-renowned-scientists-301449815.html

futr

[crmar]

Nanalysis scientific board installed !
gr

[Hetfield]

Thanks! Good man! But I think he is from Switzerland. eom

[gever]

Nanalysis appoints Dr. René Lenggenhager to board of directors.

https://www.prnewswire.com/news-releases/nanalysis-appoints-dr-rene-lenggenhager-to-board-of-directors-301445268.html

Interesting. Wondering if his German nationality and the Bosch deal are related.

[crmar]

Thanks for posting this . I like the company and the management .
Lots of potential !


grts

[gever]

Looking forward to Q4 results.
Exciting times ahead.

[crmar]

What about the results guys ? It is a very young company but i like
what i see ....

[gever]

Sean Krakiwsky comments on the recent K-prime acquisition.

[W_vdm]

Seems like a good combination of skillsets and services to me.
K'(Prime) Technologies bringing sales network and skills along with a service organisation, which will is highly valuable to ramp up the sales of NSCI's products.

Now they got to make sure the production facility can handle the additional sales. Looking forward to it.

[ctkrod]

Another acquisition:

https://www.newswire.ca/news-releases/nanalysis-merges-with-k-prime-technologies-inc--850419567.html

[douginil]

Thanks for posting the link

[walterc]

Fellow investors,

Research Capital ($3B CAD Assets Under Management) has initiated coverage on NSCI with a price target of $1.90. I invite investors to read the full report HERE.

We continue to gain more momentum in terms of raising awareness of our exciting story and hope to have more good news to you in the weeks to come.



As always, please contact me with any questions, feedback, or inquiries via phone or email using the contact details below and thank you as always for your continued support. To read the latest new on Nanalysis, please navigate to our Company News page by clicking HERE.

Best regards,

Matt Sellers
Investor Relations
Nanalysis Scientific Corp.
TSXV:NSCI, OTCQX:NSCIF, FRA:1N1

Mobile: [phone] (Whatsapp)
Office: +1.403.769.9499

nanalysis.com


Bay 1, 4600 – 5 St. NE, Calgary, Alberta, Canada T2E 7C3
Connect with us on Twitter and LinkedIn

[walterc]

very interesting presentation , especially the Q&A session

[NEgoodlife]

That makes more sense. Thanks.

[walterc]

I think it will only be used to defend the shareprice against abnormal decreases.

[ctkrod]

Agreed.

[NEgoodlife]

Using funds in this manner to provide shareholder value is a very strong indicator of confidence. Thanks for sharing the news.

[walterc]

CALGARY, AB, Oct. 21, 2021 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased to announce that it has received conditional acceptance from the TSX Venture Exchange to make a Normal Course Issuer Bid ("NCIB") to purchase for cancellation, during the 12-month period starting October 25, 2021, up to 3,844,081 of the Common Shares, representing 5% of the Common Shares outstanding as of October 25, 2021. The program will end on October 24, 2022, the maximum amount of Common Shares is purchased before then or Nanalysis provides earlier notice of termination.
nanalysis logo (CNW Group/Nanalysis Scientific Corp.)
The purchase and payment for the Common Shares will be made by Nanalysis through the facilities of the TSX Venture Exchange. Research Capital Corp has been selected as Nanalysis' agent for the NCIB. The price paid for the Common Shares will be, subject to NCIB pricing rules contained in securities laws, the prevailing market price of such Common Shares on the TSX Venture Exchange at the time of such purchase. Nanalysis intends to fund the purchases out of available cash.
Nanalysis believes that the market price of its Common Shares may not reflect their underlying value and the Board of Directors has authorized this initiative because, in the Board's opinion, the proposed purchase of Common Shares pursuant to the NCIB could constitute an appropriate use of Nanalysis' funds, and the repurchase of its Common Shares is one way of creating shareholder value and provides corporate flexibility.
To the knowledge of Nanalysis, no director, senior officer or other insider of the Nanalysis currently intends to sell any Common Shares under the NCIB. However, sales by such persons through the facilities of the TSX Venture Exchange may occur if the personal circumstances of any such person changes or any such person makes a decision unrelated to these NCIB purchases. The benefits to any such person whose Common Shares are purchased would be the same as the benefits available to all other holders whose Common Shares are purchased.


•

[Oleblue]

You can still listen to the webinar, just sign up.

[crmar]

I will , thank you !

[walterc]

I recommend to listen to the video once it is out. Very inspiring

[crmar]

Thanks for posting this Walter , i bought the stock 3 months ago , i have the feeling this is a very hidden hidden hidden stock with a good management . Is there strong competition in what they do ?

thank you

[walterc]

from Martin Gagel

I'll be posting the webinar onto YouTube this weekend.

Here's my channel, and please subscribe and you'll be notified when it gets posted.
I publish it on YouTube on Sunday morning Pacific Time - I'm in Vancouver.
YouTube - Radius Research

[walterc]

I asked for a reply

This is the mail I sent them

One of the best webinars I have followed in my career . You guys are getting better everytime. .I learn something more everytime I listen.
I also have to congratulate the interviewer with asking the right questions.
Happy to b e a shareholder here and holding very tight to my shares.

[douginil]

Thanks Walter for the comment about the webinar. It would be appreciated if you posted a link to a replay if it is made available.

Thanks Doug

[walterc]

Just finished listening to one of the best webinars I ever participated. Bot Sean and Luke were outstanding and the interviewer asked the right questions. Hopefully there will be a replay. The shareprice is going to follow the LWLG pattern in the next years.

[Oleblue]

LD Micro Presentation

https://me21.mysequire.com/recording?session_id=e5f371a2-9484-4668-b7af-07ce473dd83e

[crmar]

Thanks Walter ...bedankt .

[walterc]

yes indeed

Elysee will benefit in 2022 from being in US Vanadium.

[crmar]

Thanks for writing this Walter , what about elysee development comp ?
If i am right they presented the same day , do you see there potential ?

thank you

[walterc]

no video was made

it was this presentation with afterwards Q&A

https://static1.squarespace.com/static/5707ede0d210b8708e037a1e/t/6127cff9adffe444e82ea3d2/1629999099902/Nanalysis+Scientific+Corp+pres+v5.1.pdf

[W_vdm]

Hello Walter,

Are these presentations accessible for public audience/retail investors?
If so, is there somewhere additional information can be found?

Thanks in advance

[gever]

Indeed, very positive and informative report, lots of information and great prospects.
I'm going to read it a 3rd time to let all the positive info sink down.
It for sure puts a heavy burden on management's shoulders to live up to the expectations put forward.

Come on Sean, you can make it happen.
Smash that puck!!!

[walterc]

we have a presentation in Antwerp next Monday and Tuesday in Utrecht.

surprised there is so litlle reaction on this excellent report. This company is a jewel in the making

[ctkrod]

New research report out:

https://advisor.echelonpartners.com/research/content/nanalysisinitiation09212021.pdf

[ombowstring]

Thanks for the info.

[reading]

Not so relevant at this stage for this company I would say, but it was a 220k profit. Much more important is the development of unearned income, backlog and cash situation. The execution of Business plan seems almost perfect, very nice to see. Remains strong buy, as this might be a take-over target as well.

[ombowstring]

After looking through the Q2 results, I couldn't figure out if they made a profit or had a loss.

[ctkrod]

Things seem to be humming along nicely. Thanks for the link.

[gever]

Sean Krakiwsky comments on Q2 financial results and future outlook.

[gever]

Nanalysis Announces Q2 Financial Results
https://www.newswire.ca/news-releases/nanalysis-scientific-corp-reports-second-quarter-2021-financial-results-804148799.html

[gever]

Nanalysis' vision on future medical applications.